Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [145]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“non-ICU), presence of a central venous catheter, receipt of total parenteral nutrition (TPN) or mechanical ventilation at the onset of SAB, source of bacteremia, and severity of illness at the onset of SAB (as calculated on the basis of the APACHE II score [17]).”
MethodCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770 · cited 1×
“Only cases of SAB that occurred 2 days after hospital admission and that met the Centers for Disease Control and Prevention (CDC) criteria for bloodstream infection were included in the analysis [15].”
MethodIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[11] reported that patients who received inappropriate empirical therapy for bloodstream infections in the ICU were at an almost 7-fold higher risk of mortality, compared with patients who received adequate antimicrobial therapy.”
Background(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik, & Pitlik (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00379.x · Cited by 685 · cited 1×
“4%) of 398 patients with SAB did not receive appropriate therapy 48 h after the first positive blood culture result was obtained [9].”
BackgroundBoyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1148-1153.1994 · Cited by 485 · cited 1×
“The widespread use of vancomycin to treat methicillinresistant Staphylococcus aureus (MRSA) infection has coincided with an increased incidence of vancomycinresistant enterococci (VRE) infections, and numerous studies have suggested an association between vancomycin use and the emergence of VRE [ 1-5].”
Background
Cited by
Items 101–200 of 650
Hoste, E. A. J., Blot, S. I., Lameire, N. H., Vanholder, R. C., De Bacquer, D., & Colardyn, F. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000110182.14608.0c · Cited by 99
Casapao, A. M., Lodise, T. P., Davis, S. L., Claeys, K. C., Kullar, R., Levine, D. P., & Rybak, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03970-14 · Cited by 101
“apy (8) and since the animal (9) and in vitro pharmacodynamics studies (10) used to define the AUC/MIC exposure target for vancomycin assessed the relationship between exposure and bacterial killing during the first 24 h of therapy.”
BackgroundSelf-citationManagement of methicillin-resistant Staphylococcus aureus infections
Garau, J., Bouza, E., Chastre, J. E., Gudiol, F., & Harbarth, S. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02701.x · Cited by 100
“aureus bacteraemia beyond 48 h is associated with increased mortality [60].”
BackgroundCorona, A., Bertolini, G., Lipman, J., Wilson, A. P., & Singer, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq088 · Cited by 90
Cost-Effectiveness of Routine18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia
Vos, F. J., Bleeker‐Rovers, C. P., Kullberg, B. J., Adang, E., & Oyen, W. J. G. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089714 · Cited by 97
“Delayed diagnosis of disease activity and subsequent treatment is one of the most important indicators for a complicated outcome (12).”
BackgroundDomenico, E. G. D., Rimoldi, S. G., Cavallo, I., D’Agosto, G., Trento, E., Cagnoni, G., Palazzin, A., Pagani, C., Romeri, F., Vecchi, E. D., et al. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1596-2 · Cited by 96
Jaruratanasirikul, S., Thengyai, S., Wongpoowarak, W., Wattanavijitkul, T., Tangkitwanitjaroen, K., Sukarnjanaset, W., Jullangkoon, M., & Samaeng, M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04166-14 · Cited by 96
Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study
Yılmaz, M., Elaldı, N., Balkan, İ. İ., Arslan, F., Batırel, A. A., Bakıcı, M. Z., Gözel, M. G., Alkan, S., Çelik, A. D., Yetkin, M. A., et al. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0122-8 · Cited by 94
“looked at as to which patient subgroups would actually benefit greatest from timing of empirical antibiotics, they found that patients with severe disease benefitted most [56].”
BackgroundThe importance of appropriate initial antibiotic therapy for hospital-acquired infections
Kollef, M. H. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.002 · Cited by 94
The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit560 · Cited by 90
Casapao, A. M., Leonard, S. N., Davis, S. L., Lodise, T. P., Patel, N., Goff, D. A., LaPlante, K. L., Potoski, B. A., & Rybak, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00380-13 · Cited by 85
“Death was considered to be attributed to MRSA infection as described previously (28, 31) if one of the following criteria was present: (i) blood cultures were positive for MRSA at the time of death, (ii) death occurred before resolution of signs and symptoms of MRSA infection, (iii) death occurred 14 days after the on…”
BackgroundMethodSelf-citationNagao, M., Iinuma, Y., SAITO, T. K., Matsumura, Y., Shirano, M., Matsushima, A., Takakura, S., Ito, Y., & Ichiyama, S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03156.x · Cited by 86
Mortin, L. I., Li, T., Van Praagh, A. D. G., Zhang, S., Zhang, X.-X., & Alder, J. D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00738-06 · Cited by 80
“aureus bacteremia was a statistically significant, independent predictor of infection-related mortality (22, 30).”
BackgroundDiagnosis of bloodstream infections in immunocompromised patients by real-time PCR
Varani, S., Stanzani, M., Paolucci, M., Melchionda, F., Castellani, G., Nardi, L., Landini, M. P., Baccarani, M., Pession, A., & Sambri, V. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.03.001 · Cited by 85
Gram‐Negative Bacteremia upon Hospital Admission: When Should Pseudomonas aeruginosa Be Suspected?
Schechner, V., Junior, V. A. N., Kaye, K. S., Leshno, M., Giladi, M., Rohner, P., Harbarth, S., Anderson, D. J., Karchmer, A. W., Schwaber, M. J., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596709 · Cited by 85
“proved outcomes [4–9].”
Paulsen, J., Mehl, A., Askim, Å., Solligård, E., Åsvold, B. O., & Damås, J. K. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0849-4 · Cited by 83
“Delay of adequate treatment is of clinical importance because of the associated increased risk of infection-related mortality [36].”
BackgroundKollef, M. H., Napolitano, L. M., Solomkin, J. S., Wunderink, R. G., Bae, I., Fowler, V. G., Balk, R. A., Stevens, D. L., Rahal, J. J., Shorr, A. F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590937 · Cited by 69
“[89] evaluated the impact of delayed effective therapy on 167 retrospectively iden-”
BackgroundLockwood, A. M., Perez, K. K., Musick, W. L., Ikwuagwu, J. O., Attia, E., Fasoranti, O., Cernoch, P. L., Olsen, R. J., & Musser, J. M. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.313 · Cited by 82
“Delays in treatment have been associated with increased morbidity and mortality resulting in detrimental outcomes for patients.(5,6) With mortality increasing by the hour for patients with BSI, reducing treatment time is essential to optimize outcomes.”
BackgroundAntimicrobial Susceptibility Testing: A Primer for Clinicians
Kuper, K. M., Boles, D. M., Mohr, J., & Wanger, A. R. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.11.1326 · Cited by 82
Optimizing Antimicrobial Therapy of Sepsis and Septic Shock: Focus on Antibiotic Combination Therapy
Vázquez‐Grande, G., & Kumar, A. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398742 · Cited by 82
Kim, S.-H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh366 · Cited by 80
“... Previous antibiotic use 28 (93) 78 (80) 0.09 Previous operation 12 (40) 35 (36) 0.69 Defervescence [days, median (range)] 3.5 (1 ‐20) 4.0 (1‐ 24) 0.56 Metastatic infection 2 (7) 16 (17) 0.24 Infective endocarditis 0 (0) 4 (4) 0.57 Overall deaths 15 (50) 51 (53) 0.81 30 day deaths 11 (37) 40 (41) 0.66 S. aureus bac…”
InfluentialGómez, J., García-Vázquez, E., Baños, R., Canteras, M., Ruiz, J., Baños, V., Herrero, J. A., & Valdés, M. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0272-x · Cited by 81
Lueangarun, S., & Leelarasamee, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/765205 · Cited by 62
“5%, were also described by several previous reports, which resulted in high mortality rate from 35% to 70% [1, 2, 17–27].”
BackgroundRisk Factors for Ineffective Therapy in Patients With Bloodstream Infection
McDonald, J. R., Friedman, N. D., Stout, J. E., Sexton, D. J., & Kaye, K. S. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.308 · Cited by 81
“Early administration of effective antimicrobial therapy to patients with bloodstream infection has been repeatedly shown to improve mortality in patients with community-acquired and nosocomial bloodstream infection.(2,7-18) Ineffective empirical therapy, defined as empirical therapy that is inactive (as determined by…”
BackgroundDrusano, G. L., Liu, W., Fikes, S., Cirz, R. T., Robbins, N., Kurhanewicz, S., Rodriquez, J. L., Brown, D., Baluya, D. L., & Louie, A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu237 · Cited by 81
“An example is staphylococcal bacteremia [10].”
McLean, K. A., Mountain, K. E., Shaw, C. A., Drake, T. M., Pius, R., Knight, S. R., Fairfield, C. J., Sgrò, A., Bouamrane, M.-M., Cambridge, W. A., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00526-0 · Cited by 80
Tang, H.-J., Chen, C.-C., Cheng, K.-C., Toh, H.-S., Su, B.-A., Chiang, S.-R., Ko, W.-C., & Chuang, Y.-C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr535 · Cited by 74
Kim, H. B., Park, W. B., Lee, J. H., Kang, C., Bang, J.-W., Kim, H. B., Kim, N.-J., Kim, E.-C., Oh, M., & Choe, K. W. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01294.x · Cited by 78
Gudiol, F., Aguado, J. M., Almirante, B., Bouza, E., Cercenado, E., Domínguez, M. Á., Gasch, O., Lora-Tamayo, J., Miró, J. M., Palomar, M., et al. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.03.015 · Cited by 78
Wang, H.-Y., Kim, S., Kim, J., Park, S. D., Uh, Y., & Lee, H. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00389-14 · Cited by 77
“hospitals and continues to increase (4).”
Empiric Antimicrobial Therapy in Severe Sepsis and Septic Shock: Optimizing Pathogen Clearance
Liang, S. Y., & Kumar, A. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-015-0493-6 · Cited by 76
The usefulness of whole genome sequencing in the management of Staphylococcus aureus infections
Price, J. R., Gordon, N. C., Crook, D. W., Llewelyn, M., & Paul, J. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12109 · Cited by 75
“Prompt effective antibiotic treatment is important in order to optimize clinical outcome [8].”
BackgroundMandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality
Tissot, F., Calandra, T., Prod’hom, G., Taffé, P., Zanetti, G. M. R., Greub, G., & Senn, L. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.004 · Cited by 75
Kim, J., Gregson, D. B., Ross, T., & Laupland, K. B. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.06.001 · Cited by 75
The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes
Griffith, M., Gross, A. E., Sutton, S. H., Bolon, M. K., Esterly, J. S., Patel, J. A., Postelnick, M. J., Zembower, T., & Scheetz, M. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir954 · Cited by 75
“outcomes [5–8, 14].”
Paule, S. M., Pasquariello, A. C., Thomson, R. B., Kaul, K. L., & Peterson, L. R. (2005) · American Journal of Clinical Pathology · doi:10.1309/6ea3-u9v8-ncll-gkqn · Cited by 74
Lee, S. Y., Kuti, J. L., & Nicolau, D. P. (2005) · Surgical Infections · doi:10.1089/sur.2005.6.283 · Cited by 72
Davis, S. L., Vazquez, J. A., & Mckinnon, P. S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h516 · Cited by 71
Self-citationAntimicrobial Therapy for Life-threatening Infections: Speed is Life
Funk, D. J., & Kumar, A. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.09.008 · Cited by 70
Blot, S. I., Lipman, J., Roberts, D. M., & Roberts, J. A. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.01.015 · Cited by 69
“The reported clinical outcome thresholds for administering the first antimicrobial dose from onset of symptoms range from 48 hours (bloodstream infection) (Lodise et al., 2003; Tabah et al., 2012) to less than 4 hours of arrival at the hospital (community-acquired pneumonia) (Blot et al.”
BackgroundTang, W., Shen, Z., Guo, J., & Sun, S. (2016) · International Journal of COPD · doi:10.2147/copd.s109570 · Cited by 69
Lodise, T. P., Miller, C., Graves, J. P., Furuno, J. P., McGregor, J. C., Lomaestro, B. M., Graffunder, E. M., & McNutt, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00851-06 · Cited by 69
“the harm caused by delayed treatment (19, 22, 23, 25, 26).”
BackgroundMethodSelf-citationManagement of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 68
Clerc, O. F., Prod’hom, G., Senn, L., Jaton, K., Zanetti, G. M. R., Calandra, T., & Greub, G. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12329 · Cited by 68
MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003
Wyllie, D. H., Peto, T., & Crook, D. W. (2005) · BMJ · doi:10.1136/bmj.38558.453310.8f · Cited by 68
Hamandi, B., Holbrook, A. M., Humar, A., Brunton, J., Papadimitropoulos, E., Wong, G. G., & Thabane, L. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02664.x · Cited by 68
Lee, C., Wu, C.-J., Chi, C., Lee, N., Chen, P., Lee, H., Chang, C., Ko, N., & Ko, W. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.009 · Cited by 67
Early Antimicrobial Therapy in Severe Sepsis and Septic Shock
Kumar, A. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0128-x · Cited by 67
The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia
Siegman-Igra, Y., Reich, P., Orni-Wasserlauf, R., Schwartz, D., & Giladi, M. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510038488 · Cited by 67
[Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].
Mensa, J., Barberán, J., Llinares, P., Picazo, J. J., Bouza, E., Álvarez-Lerma, F., Borges, M. D. S., Serrano, R., León, C., Guirao, X., et al. (2008) · PubMed · Cited by 65
Vascular Catheter-Associated Infections: A Microbiological and Therapeutic Update
Viale, P., & Stefani, S. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.3.235 · Cited by 66
Marchaim, D., Kaye, K. S., Fowler, V. G., Anderson, D. J., Chawla, V., Golan, Y., Karchmer, A. W., & Carmeli, Y. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02934.x · Cited by 65
“aureus infections in various clinical syndromes and scenarios also showed correlation with increased mortality [16,19–22].”
BackgroundMuthucumarana, K., Howson, P., Crawford, D., Burrows, S., Swaminathan, R., & Irish, A. B. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.05.003 · Cited by 64
Jeon, J. H., Kim, K., Han, W. D., Song, S. H., Park, K. U., Rhee, J. E., Song, K., Park, W. B., Kim, E. S., Park, S., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06212-11 · Cited by 63
“While there is evidence that discordant treatment has a negative impact on clinical outcome (6, 10, 14), its impact is known to be variable depending on the site of infection (7).”
BackgroundSurgical Site Infections: Does Inadequate Antibiotic Therapy Affect Patient Outcomes?
Eagye, K. J., Kim, A., Laohavaleeson, S., Kuti, J. L., & Nicolau, D. P. (2009) · Surgical Infections · doi:10.1089/sur.2008.053 · Cited by 63
“Further, many investigations of IAT are pathogen-specific [15–17].”
Ruimy, R., Dos-Santos, M., Raskine, L., Bert, F., Masson, R., Elbaz, S., Bonnal, C., Lucet, J., Lefort, A., Fantin, B., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02250-07 · Cited by 63
“Because delayed treatment can increase the rates of prolonged hospitalization (22) and of secondary metastatic infections, such as endocarditis (10, 34) and vertebral osteomyelitis (17), the use of triplex RT-PCR should reduce both of these unwholesome events by optimizing early treatments.”
BackgroundDeRyke, C. A., & Alexander, D. P. (2009) · Hospital Pharmacy · doi:10.1310/hpj4409-751 · Cited by 63
Wenzler, E., Goff, D. A., Mangino, J. E., Reed, E. E., Wehr, A. M., & Bauer, K. A. A. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.09.018 · Cited by 62
“Prompt pathogen identification is crucial for optimizing antimicrobial therapy,withdelays in the initiationofeffectiveantibioticsassociated with poor patient outcomes (Barenfanger et al., 2008; Bauer et al., 2010; Forrest et al., 2008; Harbarth et al., 2003; Ibrahim et al., 2000; Lodise et al., 2003).”
BackgroundMoore, C. L., Hingwe, A. S., Donabedian, S. M., Perri, M. B., Davis, S. L., Haque, N. Z., Reyes, K., Vager, D. L., & Zervos, M. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.03.004 · Cited by 62
Park, K.-H., Kim, E. S., Kim, H. S., Park, S.-J., Bang, K. M., Park, H. J., Park, S.-Y., Moon, S. M., Chong, Y. P., Kim, S.-H., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks131 · Cited by 57
Rodríguez‐Baño, J., Millán, A. B., Domínguez, M. Á., Borraz, C., González, M. P., Almirante, B., Cercenado, E., Padilla, B., & Pujol, M. (2009) · Journal of Infection · doi:10.1016/j.jinf.2008.11.003 · Cited by 62
“Since these organisms are frequently multi-drug resistant, antimicrobial treatment of infections caused by MRSA is frequently inappropriate.(5,6) The impact of appropriate empirical therapy on the survival of patients with bacteraemia or other sterile-site infections due to MRSA is controversial.”
BackgroundHarris, A. D., Furuno, J. P., Roghmann, M., Johnson, J. K., Conway, L. J., Venezia, R. A., Standiford, H. C., Schweizer, M. L., Hebden, J. N., Moore, A. C., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01590-09 · Cited by 61
“aureus and MRSA infections who do not receive appropriate empiric therapy or who receive delayed appropriate therapy have worse patient outcomes (9, 11, 12).”
BackgroundSuzuki, H., Hitomi, S., Yaguchi, Y., Tamai, K., Ueda, A., Kamata, K., Tokuda, Y., Koganemaru, H., Kurihara, Y., Ishikawa, H., et al. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.08.019 · Cited by 61
“aureus bacteremia [10].”
Carver, P. L., Lin, S., DePestel, D. D., & Newton, D. W. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00801-08 · Cited by 60
“aureus bacteremia was detected was drawn (2).”
Carrigan, S. D., Scott, G., & Tabrizian, M. (2005) · Langmuir · doi:10.1021/la0503294 · Cited by 60
Holcman, K., Szot, W., Rubiś, P., Leśniak‐Sobelga, A., Hlawaty, M., Wiśniowska‐Śmiałek, S., Małecka, B., Ząbek, A., Boczar, K., Stępień, A., et al. (2018) · International journal of cardiac imaging · doi:10.1007/s10554-018-1487-x · Cited by 59
Pfaller, M. A., Carvalhaes, C. G., Smith, C. J., Diekema, D. J., & Castanheira, M. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115016 · Cited by 49
Emergence of Antibiotic Resistance in Infected Pancreatic Necrosis
Waele, J. J. D., Vogelaers, D., Hoste, E., Blot, S., & Colardyn, F. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.12.1371 · Cited by 57
Dryden, M., Andrašević, A. T., Bassetti, M., Bouza, E., Chastre, J. E., Cornaglia, G., Esposito, S., French, G. L., Giamarellou, H., Gyssens, I. C., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03135.x · Cited by 57
“Delay in the administration of adequate antimicrobial treatment to critically ill patients with MRSA bloodstream infections increases the risk of mortality associated with these infections [25].”
BackgroundBiophysical separation of Staphylococcus epidermidis strains based on antibiotic resistance
Jones, P. V., Hilton, S. H., Davis, P., McLemore, R. Y., McLaren, A. C., & Hayes, M. A. (2015) · The Analyst · doi:10.1039/c5an00906e · Cited by 56
Felsenstein, S., Bender, J. M., Sposto, R., Gentry, M., Takemoto, C., & Bard, J. D. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0119-oa · Cited by 56
Arshad, S., Huang, V., Hartman, P., Perri, M. B., Moreno, D., & Zervos, M. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.01.019 · Cited by 56
“However, in recent decades there have been increasing reports of vancomycin failure in patients with serious MRSA infections, such as bacteremia and infective endocarditis.(12,13) Furthermore, the reporting of increasing vancomycin MICs poses a challenge for clinicians in maximizing the pharmacodynamic parameters of v…”
BackgroundPerlin, D. S., & Wiederhold, N. P. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix121 · Cited by 49
Naber, C. K., Baddour, L. M., Giamarellos‐Bourboulis, E. J., Gould, I. M., Herrmann, M., Hoen, B., Karchmer, A. W., Kobayashi, Y., Kozlov, R. S., Lew, D., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598185 · Cited by 56
“Use of an inadequate empirical treatment regimen is known to have detrimental effects and is associated with higher inhospital mortality [18, 19], irrespective of the pathogen or other risk factors for mortality [20].”
BackgroundImportance of Adequate Initial Antimicrobial Therapy
Ramphal, R. (2005) · Chemotherapy · doi:10.1159/000086574 · Cited by 55
“Ineffective empirical therapy, ineffective definitive therapy and delays in effective therapy led to near-significant increases in mortality. Similar observations on delays in therapy have been made with S. aureus bacteremia [”
ResultHo, Y., Chang, S., Lin, S.-R., & Wang, W. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01197-08 · Cited by 55
“64 Vancomycin 12 (60) 5 (71) 7 (54) Teicoplanin 8 (40) 2 (29) 6 (46)”
BackgroundTreatment challenges in the management of complicated skin and soft-tissue infections
Eisenstein, B. I. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01922.x · Cited by 54
Nickerson, E. K., Wuthiekanun, V., Wongsuvan, G., Limmathurosakul, D., Srisamang, P., Mahavanakul, W., Thaipadungpanit, J., Shah, K. R., Arayawichanont, A., Amornchai, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006512 · Cited by 54
“Time to the first dose of effective antibiotics has been related to outcome for a range of bacterial infectious diseases in the developed world [13,27], and held true in this study of S.”
BackgroundQian, Q., Eichelberger, K., & Kirby, J. E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00369-07 · Cited by 54
Kang, C., Song, J., Chung, D. R., Peck, K. R., Ko, K. S., Yeom, J., Kim, S., Chang, H., Ys, K., Jung, S., et al. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.07.011 · Cited by 54
“aureus bacteremia, inappropriate initial antimicrobial therapy was associated with higher mortality.(18,20) Thus, further investigation is needed to determine whether appropriate initial antimicrobial therapy improves outcome in patients with S.”
BackgroundSun, H. K., Kuti, J. L., & Nicolau, D. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181528.88571.9b · Cited by 54
Diagnosis and treatment of severe sepsis
Claessens, Y.-É., & Dhainaut, J.-F. (2007) · Critical Care · doi:10.1186/cc6153 · Cited by 54
“Such a lack of aggressive and early antimicrobial therapy has been identified in various settings in which patients were being treated for such conditions as meningitis, cancer, CAP, and nosocomial pneumonia [27-33].”
BackgroundFang, C.-T., Shau, W.-Y., Hsueh, P.-R., Chen, Y.-C., Wang, J.-T., Hung, C.-C., Huang, L. Y. L., & Chang, S.-C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl006 · Cited by 53
Highly Sensitive Detection of Staphylococcus aureus Directly from Patient Blood
Banada, P. P., Chakravorty, S., Shah, D., Burday, M., Mazzella, F. M., & Alland, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031126 · Cited by 53
“Early diagnosis and appropriate treatment of sepsis has been shown to decrease life-threatening complications [1,2,3,4,5].”
BackgroundKullar, R., McKinnell, J. A., & Sakoulas, G. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu583 · Cited by 53
“appropriate antimicrobial therapy as an integral determinant of clinical outcomes for severe diseases, including MRSAB [12, 13].”
BackgroundGasch, O., Camoez, M., Dominguez, M. A., Padilla, B., Pintado, V., Almirante, B., Lepe, J. A., Lagarde, M., Ruiz de Gopegui, E., Martinez, J. A., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt016 · Cited by 52
Bhowmick, T., Mirrett, S., Reller, L. B., Price, C. S., Qi, C., Weinstein, M. P., & Kirn, T. J. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02967-12 · Cited by 52
“While it is unclear whether appropriate initial antibiotic therapy for the treatment of SAB affects mortality (19), earlier therapy appears to decrease the length of bacteremia and fever in the patient (22, 23), and delayed treatment is an independent predictor of infection-related mortality and associated with increa…”
BackgroundCreel, A. M., Durham, S. H., Benner, K. W., Alten, J. A., & Winkler, M. K. (2009) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181988798 · Cited by 52
Gasch, O., Ayats, J., Domínguez, M. Á., Tubau, F., Liñares, J., Peña, C., Grau, I., Pallarés, R., Gudiol, F., Ariza, J., et al. (2011) · Medicine · doi:10.1097/md.0b013e31822f0b54 · Cited by 51
Wong, D., Wong, T., Romney, M. G., & Leung, V. C. M. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0143-3 · Cited by 51
“aureus (MRSA) at some centres [3–8].”
Morbidity associated with Pseudomonas aeruginosa bloodstream infections
Scheetz, M. H., Hoffman, M. J., Bolon, M. K., Schulert, G. S., Estrellado, W., Baraboutis, I. G., Sriram, P., Dinh, M., Owens, L. K., & Hauser, A. R. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.02.006 · Cited by 50
“Delay in administration of appropriate antibiotic agents has also been shown to affect outcomes of bloodstream infections (Kang et al., 2003; Lodise et al., 2003).”
BackgroundGiachetto, G., Telechea, H., Speranza, N., Oyarzun, M., Nanni, L., & Menchaca, A. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181fe4047 · Cited by 50
“In this situation, a loading dose between 18 and 24 mg/kg is recommended (23, 24).”
BackgroundCurrent challenges in the management of the infected patient
Nicolau, D. P. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000393483.10270.ff · Cited by 50
Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia
Murray, R. J., Lim, T. T., Pearson, J. C., Grubb, W. B., & Lum, G. D. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.11.008 · Cited by 50
Schweizer, M. L., Furuno, J. P., Harris, A. D., Johnson, J. K., Shardell, M. D., McGregor, J. C., Thom, K. A., Sakoulas, G., & Perencevich, E. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011432 · Cited by 48
“did not differentiate between empiric and definitive antibiotic therapy [4,6,8].”
BackgroundAPPROPRIATE AND TIMELY EMPIRICAL ANTIMICROBIAL TREATMENT OF ICU INFECTIONS - A ROLE FOR CARBAPENEMS
COLARDYN, F. A. (2005) · Acta Clinica Belgica · doi:10.1179/acb.2005.011 · Cited by 49
Resistance to Antimicrobial Agents: An Update
Rybak, M. J. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.18.203s.52236 · Cited by 48
Self-citationPharmacokinetics and Pharmacodynamics: Optimal Antimicrobial Therapy in the Intensive Care Unit
Lodise, T. P., & Drusano, G. L. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.003 · Cited by 48
Self-citationStein, M., Lipman‐Arens, S., Oved, K., Cohen, A., Bamberger, E., Navon, R., Boico, O., Friedman, T., Etshtein, L., Paz, M., et al. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.11.011 · Cited by 47
Young, B. E., Lye, D. C., Krishnan, P., Chan, S. P., & Leo, Y. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-298 · Cited by 47
“An increased mortality with these infections correlates with delayed recognition and inadequate empirical therapy [11,12].”
Background
Metadata
- Authors
- Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J.
- Affiliations
- Detroit Receiving Hospital (US)
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Corresponding author
- McKinnon, Peggy S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 36
- Issue
- 11
- Pages
- 1418-1423
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2102463930
- Cited by
- 604
- References
- 24
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 28 · 2019: 17 · 2018: 18 · 2017: 26 · 2016: 19 · 2015: 40 · 2014: 26 · 2013: 37 · 2012: 31
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- Staphylococcus aureus bacteremia, nosocomial infections, delayed antibiotic treatment, mortality, length of hospital stay, treatment timing, classification and regression trees
- MeSH terms
- Anti-Bacterial Agents, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Cohort Studies, Methicillin Resistance, Bacteremia, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.